RAYMOND JAMES & ASSOCIATES - PHASEBIO PHARMACEUTICALS INC ownership

Back to all holdings Add to watchlist

PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 52 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
RAYMOND JAMES & ASSOCIATES ownership history of PHASEBIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$3,000
-66.7%
15,5000.0%0.00%–
Q2 2022$9,000
-55.0%
15,5000.0%0.00%–
Q1 2022$20,000
-50.0%
15,5000.0%0.00%–
Q4 2021$40,000–15,500–0.00%–
 Download
Other shareholders

There were no reported owners of PHASEBIO PHARMACEUTICALS INC in Q4 2021.

NameSharesValueWeighting ↓
View complete list of PHASEBIO PHARMACEUTICALS INC shareholders